1 |
Abdollahi A, Lipson KE, Sckell A, Zieher H, Klenke F, Poerschke D, Roth A, Han X, Krix M, Bischof M, Hahnfeldt P, Grone HJ, Debus J, Hlatky L, Huber PE. Combined therapy with direct and indirect angiogenesis inhibition results in enhanced antiangiogenic and antitumor effects. Cancer Res. 2003. 63: 8890-8898.
|
2 |
Abou-Nassar K, Brown JR. Novel agents for the treatment of chronic lymphocytic leukemia. Clin Adv Hematol Oncol. 2010. 8: 886-895.
|
3 |
Brack SS, Dinkelborg LM, Neri D. Molecular targeting of angiogenesis for imaging and therapy. Eur J Nucl Med Mol Imaging. 2004. 31: 1327-1341.
|
4 |
Eberhard A, Kahlert S, Goede V, Hemmerlein B, Plate KH, Augustin HG. Heterogeneity of angiogenesis and blood vessel maturation in human tumors: implications for antiangiogenic tumor therapies. Cancer Res. 2000. 60: 1388-1393.
|
5 |
Folkman J. Tumor angiogenesis: therapeutic implications. N Engl J Med. 1971. 285: 1182-1186.
DOI
ScienceOn
|
6 |
Folkman J. Angiogenesis: an organizing principle for drug discovery? Nat Rev Drug Discov. 2007. 6: 273-286.
DOI
ScienceOn
|
7 |
Liekens S, De Clercq E, Neyts J. Angiogenesis: regulators and clinical applications. Biochem Pharmacol. 2001. 61: 253-270.
DOI
ScienceOn
|
8 |
Hayden EC. Cutting off cancer's supply lines. Nature. 2009. 458: 686-687.
DOI
ScienceOn
|
9 |
Jung YD, Ahmad SA, Akagi Y, Takahashi Y, Liu W, Reinmuth N, Shaheen RM, Fan F, Ellis LM. Role of the tumor microenvironment in mediating response to anti-angiogenic therapy. Cancer Metastasis Rev. 2000. 19: 147-157.
DOI
ScienceOn
|
10 |
Kerbel R, Folkman J. Clinical translation of angiogenesis inhibitors. Nat Rev Cancer. 2000. 2: 727-739.
|
11 |
Lund EL, Bastholm L, Kristjansen PE. Therapeutic synergy of TNP-470 and ionizing radiation: effects on tumor growth, vessel morphology, and angiogenesis in human glioblastoma multiforme xenografts. Clin Cancer Res. 2000. 6: 971-978.
|
12 |
Paez-Ribes M, Allen E, Hudock J, Takeda T, Okuyama H, Vinals F, Inoue M, Bergers G, Hanahan D, Casanovas O. Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis. Cancer Cell. 2009. 15: 220-231.
DOI
ScienceOn
|
13 |
Ryan PM. Therapeutic area crossroads: anti-angiogenesis. Nat Rev Drug Discov. 2008. 7: 115-116.
DOI
ScienceOn
|
14 |
Tuma, Rabiya S. Taking Cues from Recent Blockbusters. Pharma DD. 2007. 2: 28-30.
|
15 |
Willis LM, El-Remessy AB, Somanath PR, Deremer DL, Fagan SC. Angiotensin receptor blockers and angiogenesis: clinical and experimental evidence. Clin Sci. 2011. 120: 307-319.
DOI
ScienceOn
|